Skip to content
Delayed ~15 min

LRCX Lam Research

Permanent stock page ↗

Information Technology · S&P 500 · Nasdaq 100

Next earnings: Wed 27 Jan 2027 · estimated

What 40 analyst firms say about Lam Research: their latest ratings, price targets and how far the stock is from them. How it works

185.20 USD−36.23 (−16.36%) today
Price as of 5 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+102.0%to the avg target 374.17 USD+188.97 USD
Buy 28 · Hold 8 · Sell 0

36 rated views · 40 analyst/firm records · 40 firms

Latest report23 Oct 2026avg report date 4 Aug
Target rangePrice is below every target

Radar score

  • S&P 500 · Top Picks · 6MStrong · #15 in the index91
  • S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8056
Other indices (1)
  • Nasdaq 100 · Top Picks · 6MGood · #9 in the index83
  • Nasdaq 100 · Safest consensus · 6MBelow the Radar threshold of 8055

Recent analyst activity · last 90 days

Our tracked history has 20 reports on LRCX from 17 analyst firms in the last 90 days (40 firms in the past year).

Comparing each firm's latest target with its previous one: 3 raised their price target, 7 lowered it, 2 left it unchanged and 2 have their first observed target in the past year.

Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.

Latest observed target change: Argus raised its target from $280.00 (set 3 Feb 2026) to $375.00 on 23 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusJames N KelleherBuy23 Oct 2026375.00 USD
B Riley SecuritiesCraig EllisBuy1 Oct 2026390.00 USD
Bank of America SecuritiesVivek AryaBuy22 Oct 2026345.00 USD
BarclaysTom O'MalleyConflictConflicting reports · excluded11 Jun 2026335.00 USD
BerenbergTammy QiuBuy30 Jul 2026Conflicting reports · excluded
BernsteinStacy A RasgonBuy30 Jul 2026Conflicting reports · excluded
BNP Paribas ExaneJerome RamelHold29 Jan 2026260.00 USD
Cantor FitzgeraldC.J. MuseBuy29 Jun 2026500.00 USD
CITIC SecuritiesUnnamed analystBuy30 Jan 2026275.00 USD
CitigroupAtif MalikBuy22 Oct 2026435.00 USD
DBSLee K LingBuy31 Jul 2026416.00 USD
Deutsche BankMelissa WeathersBuy19 Oct 2026375.00 USD
Erste GroupStephan LingnauHold18 Sep 2026—
Erste Group BankUnnamed analystHold2 Apr 2026—
Evercore ISIMark LipacisBuy30 Jul 2026Conflicting reports · excluded
Fundamental ResearchUnnamed analyst—1 Oct 2026390.00 USD
Goldman SachsJames E SchneiderBuy23 Apr 2026Conflicting reports · excluded
HSBCAdithya MetukuHold27 Jul 2026Conflicting reports · excluded
JefferiesBlayne CurtisBuy30 Jul 2026335.00 USD
JPMorganHarlan SurBuy23 Apr 2026315.00 USD
KeyBanc Capital MarketsSteve BargerHold29 Jul 2026—
MizuhoVijay RakeshBuy22 Oct 2026360.00 USD
Morgan StanleyShane BrettBuy22 Oct 2026339.00 USD
NeedhamCharles ShiBuy22 Oct 2026290.00 USD
New Street ResearchPierre C FerraguHold30 Jul 2026Conflicting reports · excluded
OppenheimerEdward YangBuy15 Jun 2026400.00 USD
Raymond JamesUnnamed analyst—10 Jun 2026425.00 USD
RBC Capital MarketsSrini PajjuriBuy23 Apr 2026Conflicting reports · excluded
RedburnTimm Schulze-MelanderBuy30 Apr 2026420.00 USD
Seaport Research PartnersJay GoldbergBuy22 Oct 2026300.00 USD
StifelBrian ChinBuy10 Jul 2026425.00 USD
Summit InsightsUnnamed analystBuy29 Jan 2026—
Summit Insights GroupKinngai ChanBuy28 Jan 2026—
SusquehannaMehdi HosseiniBuy30 Jun 2026475.00 USD
TD CowenSreekrishnan SankarBuy14 Aug 2026400.00 USD
UBSTimothy ArcuriBuy22 Oct 2026400.00 USD
Weiss RatingsUnnamed analyst—4 Sep 2026—
Wells FargoJoe QuatrochiBuy30 Jul 2026Conflicting reports · excluded
Wolfe ResearchChristopher CasoHold29 Jan 2026—
Data feed RESEARCHResearch TeamHold22 Oct 2026Conflicting reports · excluded

Partial coverage · checked 6 Nov (6 Nov 2026, 03:57 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.